Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients.
about
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin DSolar radiation and vitamin D: mitigating environmental factors in autoimmune diseaseVitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of SupplementationVitamin D—update for the pediatric rheumatologistsThe impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.Vitamin D and autoimmune thyroid diseasesAn evaluation of high-dose vitamin D for rheumatoid arthritis.Vitamin D for health: a global perspectiveIs the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer.Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women.Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosusVitamin D levels and food and environmental allergies in the United States: results from the National Health and Nutrition Examination Survey 2005-2006Does vitamin D affect risk of developing autoimmune disease?: a systematic review.Extracellular localization of galectin-3 has a deleterious role in joint tissuesVitamin D and autoimmunity: new aetiological and therapeutic considerations.Environmental and gene-environment interactions and risk of rheumatoid arthritis.Effect of vitamin D on the recurrence rate of rheumatoid arthritis.Hypovitaminosis D among rheumatology outpatients in clinical practice.Vitamin D and human health: lessons from vitamin D receptor null mice.Serum 25-hydroxyvitamin D and biochemical markers of bone metabolism in patients with juvenile idiopathic arthritis.Calcium intervention ameliorates experimental model of multiple sclerosis.Vitamin d and cardiovascular disease.
P2860
Q26748470-03951540-E544-4DF2-8F90-43F8B27F685BQ26852741-16AADBAE-150F-472A-AB83-758E76782A33Q27011804-890A342F-5017-47C1-A8D8-BF15CFD7F909Q30375070-7E49FD91-77D5-4074-84B3-12982C7F979AQ33532591-4658D95F-17FB-4E41-B3E6-95CAAEFDE13FQ33577498-A16E37AD-F277-4AE0-A69B-16CB4024C384Q33872780-F5DB3C78-1E4A-4520-83F7-D47EDA8B7F47Q34037261-7F0F1982-E997-4A08-9169-E53C62CA4A08Q34089998-18125587-7042-4420-B7DB-08489052176FQ34565684-3AF61D3A-7A00-41CE-BE95-5A689E9D4856Q34584718-A82BFD9E-5DD4-4FFC-8202-35ED41F311DCQ34896971-5E78CD63-B5EE-46AB-A0C7-2BC8B0A33C29Q34900332-2C0BF438-BD5E-47C2-AF60-EF645FBD4D5AQ34995500-FC6D1A9B-D5FB-48FF-A0BE-9BA1DA2836ADQ35769105-D441EEF6-2431-4E9C-A315-17CF9D60FA37Q35954681-60B284D4-D659-4FD3-B873-4970C027EDA7Q36110733-37EE6363-C936-402E-9587-81CE40C9C215Q36336368-0433F9AB-8F16-49C9-86E4-80A2FA848AD7Q36843900-0F78811B-4F92-40BE-A4B3-7717532581DAQ36973933-682051FE-A401-49C7-B91B-822135C82C66Q37371332-3DF73574-8302-43ED-9CDC-44E7025DC7C5Q40542150-2CDD90FA-279B-409E-B65F-504315BDDFA1Q50937532-A7F8CE03-338B-4C2F-BEB3-5354DBEC6A7C
P2860
Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Disease modifying and immunomo ...... rheumatoid arthritis patients.
@ast
Disease modifying and immunomo ...... rheumatoid arthritis patients.
@en
type
label
Disease modifying and immunomo ...... rheumatoid arthritis patients.
@ast
Disease modifying and immunomo ...... rheumatoid arthritis patients.
@en
prefLabel
Disease modifying and immunomo ...... rheumatoid arthritis patients.
@ast
Disease modifying and immunomo ...... rheumatoid arthritis patients.
@en
P2093
P1476
Disease modifying and immunomo ...... rheumatoid arthritis patients.
@en
P2093
D Mitrovic
D Stefanovic
J Vojinovic
N Pejnovic
Z Andjelkovic
P304
P577
1999-07-01T00:00:00Z